Journal article
Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia
Canadian Journal of Psychiatry, Vol.61(5), pp.291-297
2016
PMCID: PMC4841287
PMID: 27254804
Abstract
Objective: Type 2 diabetes is commonly found in schizophrenia and is an important contributor to mortality and morbidity in this condition. Dopamine has been implicated in the aetiology of both diabetes and schizophrenia. It is possible that both disorders share a common genetic susceptibility.
Methods: In a cross-sectional study, we examined 2 dopamine D2 receptor (DRD2) single-nucleotide polymorphisms (SNPs) previously associated with schizophrenia (C939 T, rs6275 and C957 T, rs6277) along with fasting blood glucose and body mass index (BMI) in 207 antipsychotic-treated patients with schizophrenia. All participants met DSM-IV criteria for schizophrenia, and those with other psychiatric disorders were excluded. Analysis of covariance was used to compare fasting glucose results by DRD2 genotypes, after controlling for known confounds. For significant associations, follow-up Bonferroni post hoc tests examined differences in fasting glucose levels between genotypes. Specific comparisons were also made using analysis of variance and chi-square (Fisher’s exact test).
Results: The 2 DRD2 risk genotypes were associated with significant increases in blood glucose, after controlling for BMI, age, sex, dosage and type of antipsychotic medication, number of hospitalisations, and negative symptoms (rs6275, F(2, 182) ¼ 5.901, P ¼ 0.003; rs6277 SNP, F(2, 178) ¼ 3.483, P ¼ 0.033).
Conclusions: These findings support the involvement of DRD2 not only in schizophrenia but also in elevated levels of blood glucose commonly found in antipsychotic-treated patients with schizophrenia. Our data support the notion that diabetes may not merely be a comorbid condition but could be fundamentally associated with the pathogenesis of schizophrenia itself.
Details
- Title
- Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia
- Authors
- Bruce R Lawford (Author) - Royal Brisbane and Women's HospitalMark Barnes (Author) - Royal Brisbane and Women's HospitalC Phillip Morris (Author) - Queensland University of TechnologyErnest P Noble (Author) - University of California Los AngelesPhillip Nyst (Author) - Royal Brisbane and Women's HospitalKaren Heslop (Author) - Curtin UniversityRoss Young (Author) - Queensland University of TechnologyJoanne Voisey (Author) - Queensland University of TechnologyJason P Connor (Author) - Queensland University of Technology
- Publication details
- Canadian Journal of Psychiatry, Vol.61(5), pp.291-297
- Publisher
- Sage Publications, Inc.
- DOI
- 10.1177/0706743716644765
- ISSN
- 1497-0015
- PMID
- 27254804; PMC4841287
- Organisation Unit
- Office of the Deputy Vice-Chancellor (Research and Innovation); University of the Sunshine Coast, Queensland
- Language
- English
- Record Identifier
- 99550999702621
- Output Type
- Journal article
Metrics
14 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Web Of Science research areas
- Psychiatry
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites